"j&j pharma" - Google News

Yuhan gets $30 mil. from J&J as Lazcluze-Rybrevant reaches Europe - koreabiomed.com

Thu, 14 May 2026 05:51:49 GMT

Yuhan gets $30 mil. from J&J as Lazcluze-Rybrevant reaches Europe koreabiomed.com

Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts - Fierce Pharma

Fri, 08 May 2026 07:00:00 GMT

Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts Fierce Pharma

Royalty Pharma and J&J partner to develop autoimmune treatment - Reuters

Mon, 30 Mar 2026 07:00:00 GMT

Royalty Pharma and J&J partner to develop autoimmune treatment Reuters

J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales - BioSpace

Wed, 18 Mar 2026 07:00:00 GMT

J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales BioSpace

Madrigal continues MASH deal spree with $1B biobucks license for Arrowhead asset rejected by J&J - Fierce Biotech

Tue, 05 May 2026 07:00:00 GMT

Madrigal continues MASH deal spree with $1B biobucks license for Arrowhead asset rejected by J&J Fierce Biotech

J&J sets the tone for Q1 earnings with strong oncology growth - Pharmaceutical Technology

Wed, 15 Apr 2026 07:00:00 GMT

J&J sets the tone for Q1 earnings with strong oncology growth Pharmaceutical Technology

J&J Agreement Brings 15 of 17 Pharma Companies Into Trump's Drug-Pricing Effort - AJMC

Fri, 09 Jan 2026 08:00:00 GMT

J&J Agreement Brings 15 of 17 Pharma Companies Into Trump's Drug-Pricing Effort AJMC

J&J adds to pharma’s M&A spree with $3B buyout of startup Halda - BioPharma Dive

Mon, 17 Nov 2025 08:00:00 GMT

J&J adds to pharma’s M&A spree with $3B buyout of startup Halda BioPharma Dive

Pharma: J&J's broadening product pipeline can bring 'new era' - Yahoo Finance

Fri, 23 Jan 2026 08:00:00 GMT

Pharma: J&J's broadening product pipeline can bring 'new era' Yahoo Finance

J&J becomes latest pharma heavyweight to embrace MFN pricing - FirstWord Pharma

Fri, 09 Jan 2026 08:00:00 GMT

J&J becomes latest pharma heavyweight to embrace MFN pricing FirstWord Pharma

Johnson & Johnson launches ‘Generation Fine’ depression project - Fierce Pharma

Fri, 08 May 2026 07:00:00 GMT

Johnson & Johnson launches ‘Generation Fine’ depression project Fierce Pharma

J&J secures $500M Royalty backing for autoimmune antibody program - Fierce Biotech

Mon, 30 Mar 2026 07:00:00 GMT

J&J secures $500M Royalty backing for autoimmune antibody program Fierce Biotech

J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts - Pharmaceutical Technology

Fri, 09 Jan 2026 08:00:00 GMT

J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts Pharmaceutical Technology

Royalty Pharma and J&J partner to develop autoimmune treatment - Yahoo Finance

Mon, 30 Mar 2026 07:00:00 GMT

Royalty Pharma and J&J partner to develop autoimmune treatment Yahoo Finance

J&J sees AI halving the time to generate drug development leads - Reuters

Tue, 28 Apr 2026 07:00:00 GMT

J&J sees AI halving the time to generate drug development leads Reuters

Bayer falls short in bid to block J&J’s survival claims in prostate cancer clash - Fierce Pharma

Mon, 20 Apr 2026 07:00:00 GMT

Bayer falls short in bid to block J&J’s survival claims in prostate cancer clash Fierce Pharma

J&J axes $5B CAR-T dream months after touting efficacy edge - Fierce Biotech

Fri, 01 May 2026 07:00:00 GMT

J&J axes $5B CAR-T dream months after touting efficacy edge Fierce Biotech

J&J fleshes out US investment plan, telegraphing $1B cell therapy plant and 500 new jobs in PA - Fierce Pharma

Wed, 18 Feb 2026 08:00:00 GMT

J&J fleshes out US investment plan, telegraphing $1B cell therapy plant and 500 new jobs in PA Fierce Pharma

J&J strikes MFN deal with Trump, reveals plan to build 2 US manufacturing sites - Fierce Pharma

Fri, 09 Jan 2026 08:00:00 GMT

J&J strikes MFN deal with Trump, reveals plan to build 2 US manufacturing sites Fierce Pharma

Led by Darzalex surge, J&J expects revenue to reach $100B in 2026 - Fierce Pharma

Wed, 21 Jan 2026 08:00:00 GMT

Led by Darzalex surge, J&J expects revenue to reach $100B in 2026 Fierce Pharma

J&J Strengthens U.S. Pharma Supply Chain with Two Next-Gen Facilities - Inbound Logistics

Thu, 22 Jan 2026 08:00:00 GMT

J&J Strengthens U.S. Pharma Supply Chain with Two Next-Gen Facilities Inbound Logistics

J&J Joins Pharma M&A Bandwagon, to Buy Cancer Biotech for $3.05B - Yahoo Finance

Tue, 18 Nov 2025 08:00:00 GMT

J&J Joins Pharma M&A Bandwagon, to Buy Cancer Biotech for $3.05B Yahoo Finance

J&J files trade secret lawsuit against former oncology employee linked to Summit Therapeutics - Fierce Pharma

Mon, 16 Mar 2026 07:00:00 GMT

J&J files trade secret lawsuit against former oncology employee linked to Summit Therapeutics Fierce Pharma

How J&J plans to hit $100B in revenue this year - Pharma Voice

Thu, 16 Apr 2026 07:00:00 GMT

How J&J plans to hit $100B in revenue this year Pharma Voice

J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains - WSJ

Tue, 14 Oct 2025 07:00:00 GMT

J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains WSJ

J&J halts mid-stage atopic dermatitis study - FirstWord Pharma

Fri, 26 Dec 2025 08:00:00 GMT

J&J halts mid-stage atopic dermatitis study FirstWord Pharma

J&J to build $1bn US CGT manufacturing site in Pennsylvania - Pharmaceutical Technology

Thu, 19 Feb 2026 08:00:00 GMT

J&J to build $1bn US CGT manufacturing site in Pennsylvania Pharmaceutical Technology

AbbVie outlines Skyrizi defense against new J&J plaque psoriasis rival Icotyde - Fierce Pharma

Wed, 29 Apr 2026 07:00:00 GMT

AbbVie outlines Skyrizi defense against new J&J plaque psoriasis rival Icotyde Fierce Pharma

With nearly a quarter billion in Q1, J&J targets $100B revenue in 2026 - BioSpace

Tue, 14 Apr 2026 07:00:00 GMT

With nearly a quarter billion in Q1, J&J targets $100B revenue in 2026 BioSpace

J&J's Tremfya retakes TV drug ad spending crown from AbbVie - Fierce Pharma

Wed, 08 Apr 2026 07:00:00 GMT

J&J's Tremfya retakes TV drug ad spending crown from AbbVie Fierce Pharma

Bayer sues J&J over 'deeply flawed' promotional claims touting Erleada over Nubeqa - Fierce Pharma

Mon, 23 Feb 2026 08:00:00 GMT

Bayer sues J&J over 'deeply flawed' promotional claims touting Erleada over Nubeqa Fierce Pharma

J&J allots $1B to Pennsylvania plant in US manufacturing push - FirstWord Pharma

Wed, 18 Feb 2026 08:00:00 GMT

J&J allots $1B to Pennsylvania plant in US manufacturing push FirstWord Pharma

J&J, Protagonist's 'game-changer' once-daily psoriasis pill Icotyde nabs FDA approval - Fierce Pharma

Wed, 18 Mar 2026 07:00:00 GMT

J&J, Protagonist's 'game-changer' once-daily psoriasis pill Icotyde nabs FDA approval Fierce Pharma

J&J strikes deal with US government to cut drug prices, gain tariff exemptions - Reuters

Fri, 09 Jan 2026 08:00:00 GMT

J&J strikes deal with US government to cut drug prices, gain tariff exemptions Reuters

J&J: Still a Defensive Giant, or Too Dependent on Pharma? - Yahoo Finance

Fri, 26 Sep 2025 07:00:00 GMT

J&J: Still a Defensive Giant, or Too Dependent on Pharma? Yahoo Finance

J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde - Fierce Pharma

Tue, 14 Apr 2026 07:00:00 GMT

J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde Fierce Pharma

Why The Narrative Around J&J Is Shifting Amid Analyst Upgrades and Pharma Developments - Yahoo Finance

Wed, 08 Oct 2025 07:00:00 GMT

Why The Narrative Around J&J Is Shifting Amid Analyst Upgrades and Pharma Developments Yahoo Finance

J&J's Joaquin Duato joins $30M CEO pay club with 30% compensation boost for 2025 - Fierce Pharma

Wed, 11 Mar 2026 07:00:00 GMT

J&J's Joaquin Duato joins $30M CEO pay club with 30% compensation boost for 2025 Fierce Pharma

Royalty Pharma commits $500M to J&J autoimmune drug development - Investing.com

Mon, 30 Mar 2026 07:00:00 GMT

Royalty Pharma commits $500M to J&J autoimmune drug development Investing.com

AbbVie’s Skyrizi beats out J&J’s Tremfya in April drug ad spending leaderboard - Fierce Pharma

Fri, 08 May 2026 07:00:00 GMT

AbbVie’s Skyrizi beats out J&J’s Tremfya in April drug ad spending leaderboard Fierce Pharma

Pharma Pulse: J&J’s $1B Cell Therapy Hub and Hims & Hers’ Global Expansion - Pharmaceutical Commerce

Fri, 20 Feb 2026 08:00:00 GMT

Pharma Pulse: J&J’s $1B Cell Therapy Hub and Hims & Hers’ Global Expansion Pharmaceutical Commerce

J&J reportedly eyeing takeout of icotrokinra partner Protagonist - FirstWord Pharma

Fri, 10 Oct 2025 07:00:00 GMT

J&J reportedly eyeing takeout of icotrokinra partner Protagonist FirstWord Pharma

J&J sees 2026 profit above Wall Street estimates despite tariffs hit, Trump pricing deal - Reuters

Wed, 21 Jan 2026 08:00:00 GMT

J&J sees 2026 profit above Wall Street estimates despite tariffs hit, Trump pricing deal Reuters

J&J scores FDA nod for subcutaneous lung cancer shot, sharpening its challenge to Tagrisso - Fierce Pharma

Thu, 18 Dec 2025 08:00:00 GMT

J&J scores FDA nod for subcutaneous lung cancer shot, sharpening its challenge to Tagrisso Fierce Pharma

J&J's 'practice-changing' bladder cancer therapy Inlexzo lands FDA nod - Fierce Pharma

Wed, 10 Sep 2025 07:00:00 GMT

J&J's 'practice-changing' bladder cancer therapy Inlexzo lands FDA nod Fierce Pharma

FDA 'proactively' awards J&J a national priority review voucher for multiple myeloma drug combo - Fierce Pharma

Mon, 15 Dec 2025 08:00:00 GMT

FDA 'proactively' awards J&J a national priority review voucher for multiple myeloma drug combo Fierce Pharma

J&J eyes $100B in sales amid gains for cancer, immune drugs - BioPharma Dive

Wed, 21 Jan 2026 08:00:00 GMT

J&J eyes $100B in sales amid gains for cancer, immune drugs BioPharma Dive

Legend remains bullish on Carvykti growth despite threat from J&J’s Tecvayli - Fierce Pharma

Thu, 12 Mar 2026 07:00:00 GMT

Legend remains bullish on Carvykti growth despite threat from J&J’s Tecvayli Fierce Pharma

J&J says 2026 sales could top $100 billion - pharmaphorum

Thu, 22 Jan 2026 08:00:00 GMT

J&J says 2026 sales could top $100 billion pharmaphorum

FDA untitled letter lambastes claims in ad for J&J's Tremfya - Fierce Pharma

Thu, 19 Feb 2026 08:00:00 GMT

FDA untitled letter lambastes claims in ad for J&J's Tremfya Fierce Pharma

ASH: J&J makes case for Tecvayli combo as an alternative to CAR-T in 2nd-line multiple myeloma - Fierce Pharma

Tue, 09 Dec 2025 08:00:00 GMT

ASH: J&J makes case for Tecvayli combo as an alternative to CAR-T in 2nd-line multiple myeloma Fierce Pharma

J&J expands cancer portfolio with $3.05 billion Halda buy - Reuters

Mon, 17 Nov 2025 08:00:00 GMT

J&J expands cancer portfolio with $3.05 billion Halda buy Reuters

Barclays Raises Johnson & Johnson (JNJ) Price Target on Strong Pharma Momentum - Yahoo Finance

Fri, 17 Apr 2026 07:00:00 GMT

Barclays Raises Johnson & Johnson (JNJ) Price Target on Strong Pharma Momentum Yahoo Finance

Johnson & Johnson’s pipeline strategy: What does 2026 have in store for the big pharma? - Labiotech.eu

Fri, 30 Jan 2026 08:00:00 GMT

Johnson & Johnson’s pipeline strategy: What does 2026 have in store for the big pharma? Labiotech.eu

JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio? - Yahoo Finance

Mon, 27 Oct 2025 07:00:00 GMT

JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio? Yahoo Finance

JPM26: J&J leans on immunology launches to fuel annual growth - Pharmaceutical Technology

Tue, 13 Jan 2026 08:00:00 GMT

JPM26: J&J leans on immunology launches to fuel annual growth Pharmaceutical Technology

J&J, Pharma Mar Agree to End Patent Suits on Two Yondelis Copies - Bloomberg Law News

Wed, 18 Feb 2026 08:00:00 GMT

J&J, Pharma Mar Agree to End Patent Suits on Two Yondelis Copies Bloomberg Law News

Johnson & Johnson directs a new campaign for aging eyes with Naomi Watts in the spotlight - Fierce Pharma

Wed, 03 Dec 2025 08:00:00 GMT

Johnson & Johnson directs a new campaign for aging eyes with Naomi Watts in the spotlight Fierce Pharma

J&J changes New York state of mind, closing JLABS site after 8 years - Fierce Biotech

Tue, 17 Mar 2026 07:00:00 GMT

J&J changes New York state of mind, closing JLABS site after 8 years Fierce Biotech

Digital Process Twin cuts production time and costs at J&J - Siemens

Fri, 13 Feb 2026 12:12:06 GMT

Digital Process Twin cuts production time and costs at J&J Siemens

J&J's Tremfya roars into 2026 with massive TV ad spend, trailed by AbbVie's Rinvoq and Skyrizi - Fierce Pharma

Wed, 11 Feb 2026 08:00:00 GMT

J&J's Tremfya roars into 2026 with massive TV ad spend, trailed by AbbVie's Rinvoq and Skyrizi Fierce Pharma

J&J’s orthopedics selloff keeps all eyes on a thriving pharma portfolio - Pharma Voice

Thu, 16 Oct 2025 07:00:00 GMT

J&J’s orthopedics selloff keeps all eyes on a thriving pharma portfolio Pharma Voice

J&J positions its PARP combo Akeega in new prostate cancer subset with 2nd FDA nod - Fierce Pharma

Mon, 15 Dec 2025 08:00:00 GMT

J&J positions its PARP combo Akeega in new prostate cancer subset with 2nd FDA nod Fierce Pharma

In J&J talc litigation, N.J. court-appointed official recommends allowing expert testimony - Fierce Pharma

Wed, 21 Jan 2026 08:00:00 GMT

In J&J talc litigation, N.J. court-appointed official recommends allowing expert testimony Fierce Pharma

How J&J’s Deal with Trump will Reshape Pharma Value Chain - Procurement Magazine

Tue, 13 Jan 2026 08:00:00 GMT

How J&J’s Deal with Trump will Reshape Pharma Value Chain Procurement Magazine

Johnson & Johnson hands back failed eye disease gene therapy to MeiraGTx - Fierce Biotech

Thu, 16 Apr 2026 07:00:00 GMT

Johnson & Johnson hands back failed eye disease gene therapy to MeiraGTx Fierce Biotech

Spotlight On: J&J's fastest selling drugs in 2025 - FirstWord Pharma

Mon, 26 Jan 2026 08:00:00 GMT

Spotlight On: J&J's fastest selling drugs in 2025 FirstWord Pharma

J&J chief Joaquin Duato expects to find 'common ground' with Trump administration as industry's MFN talks play out - Fierce Pharma

Tue, 14 Oct 2025 07:00:00 GMT

J&J chief Joaquin Duato expects to find 'common ground' with Trump administration as industry's MFN talks play out Fierce Pharma

Novo, J&J Alzheimer’s clinical flops teach bruised field valuable lessons - Pharma Voice

Tue, 02 Dec 2025 08:00:00 GMT

Novo, J&J Alzheimer’s clinical flops teach bruised field valuable lessons Pharma Voice

JPM26: J&J reveals oncology strategy - Pharmaceutical Technology

Tue, 13 Jan 2026 08:00:00 GMT

JPM26: J&J reveals oncology strategy Pharmaceutical Technology

J&J & AbbVie: Why Big Pharma is Onshoring in the US - Manufacturing Digital

Thu, 15 Jan 2026 08:00:00 GMT

J&J & AbbVie: Why Big Pharma is Onshoring in the US Manufacturing Digital

J&J heads to regulators with Tecvayli-Darzalex combo's phase 3 win as earlier myeloma treatment - Fierce Pharma

Thu, 16 Oct 2025 07:00:00 GMT

J&J heads to regulators with Tecvayli-Darzalex combo's phase 3 win as earlier myeloma treatment Fierce Pharma

Barclays Sees Continued Strength in Johnson & Johnson (JNJ) Pharma Business - Yahoo Finance

Thu, 19 Mar 2026 07:00:00 GMT

Barclays Sees Continued Strength in Johnson & Johnson (JNJ) Pharma Business Yahoo Finance

J&J, Lilly Crest AI Wave With Nvidia Partnerships - BioSpace

Wed, 29 Oct 2025 07:00:00 GMT

J&J, Lilly Crest AI Wave With Nvidia Partnerships BioSpace

UPDATED: J&J, Legend withdraw ASH abstract assessing Carvykti against Gilead, Arcellx's rival CAR-T - Fierce Pharma

Wed, 12 Nov 2025 08:00:00 GMT

UPDATED: J&J, Legend withdraw ASH abstract assessing Carvykti against Gilead, Arcellx's rival CAR-T Fierce Pharma

Lilly's prospective cardiometabolic launches dominate list of drugs to watch in 2026: Clarivate - Fierce Pharma

Wed, 07 Jan 2026 08:00:00 GMT

Lilly's prospective cardiometabolic launches dominate list of drugs to watch in 2026: Clarivate Fierce Pharma

BMS, J&J factor in HCP education on clot-busting mechanism before milvexian data drop - Fierce Pharma

Tue, 03 Feb 2026 08:00:00 GMT

BMS, J&J factor in HCP education on clot-busting mechanism before milvexian data drop Fierce Pharma

J&J To Add 500 Jobs at New Plant, Doubling Down on North Carolina - BioSpace

Tue, 13 Jan 2026 08:00:00 GMT

J&J To Add 500 Jobs at New Plant, Doubling Down on North Carolina BioSpace

J&J's Tremfya outstrips AbbVie's Skyrizi again, closing out 2025 as December's top TV ad spender - Fierce Pharma

Tue, 06 Jan 2026 08:00:00 GMT

J&J's Tremfya outstrips AbbVie's Skyrizi again, closing out 2025 as December's top TV ad spender Fierce Pharma

A new pharma factory shows how hard it could be for drugmakers to outrun Trump's tariffs - CNBC

Thu, 21 Aug 2025 07:00:00 GMT

A new pharma factory shows how hard it could be for drugmakers to outrun Trump's tariffs CNBC

Bayer sues J&J over 'false and misleading claims' about competing prostate cancer treatments - statnews.com

Mon, 23 Feb 2026 08:00:00 GMT

Bayer sues J&J over 'false and misleading claims' about competing prostate cancer treatments statnews.com

J&J spins off orthopaedics business against positive Q3 backdrop - Pharmaceutical Technology

Tue, 14 Oct 2025 07:00:00 GMT

J&J spins off orthopaedics business against positive Q3 backdrop Pharmaceutical Technology

Tecvayli tops standard drugs in early multiple myeloma, J&J says - BioPharma Dive

Thu, 15 Jan 2026 08:00:00 GMT

Tecvayli tops standard drugs in early multiple myeloma, J&J says BioPharma Dive

FDA adds warning to label of J&J, Legend's Carvykti for potentially fatal intestinal disorder - Fierce Pharma

Mon, 13 Oct 2025 07:00:00 GMT

FDA adds warning to label of J&J, Legend's Carvykti for potentially fatal intestinal disorder Fierce Pharma

J&J Joins Pharma M&A Bandwagon, to Buy Cancer Biotech for $3.05B - Zacks Investment Research

Tue, 18 Nov 2025 08:00:00 GMT

J&J Joins Pharma M&A Bandwagon, to Buy Cancer Biotech for $3.05B Zacks Investment Research

J&J and the Jets: Pharma signs on as NFL team's medical innovation sponsor - Fierce Pharma

Wed, 22 Oct 2025 07:00:00 GMT

J&J and the Jets: Pharma signs on as NFL team's medical innovation sponsor Fierce Pharma

J&J in talks to acquire Protagonist Therapeutics - Pharmaceutical Technology

Mon, 13 Oct 2025 07:00:00 GMT

J&J in talks to acquire Protagonist Therapeutics Pharmaceutical Technology

J&J buys cancer drugmaker Halda for $3bn in latest biotech deal - Financial Times

Mon, 17 Nov 2025 08:00:00 GMT

J&J buys cancer drugmaker Halda for $3bn in latest biotech deal Financial Times

AbbVie, hitting record sales on Skyrizi gains, holds its own in growing IBD arena despite J&J competition - Fierce Pharma

Wed, 04 Feb 2026 08:00:00 GMT

AbbVie, hitting record sales on Skyrizi gains, holds its own in growing IBD arena despite J&J competition Fierce Pharma

Why Is J&J Investing US$4bn in New Pharma Manufacturing? - Construction Digital

Thu, 15 Jan 2026 08:00:00 GMT

Why Is J&J Investing US$4bn in New Pharma Manufacturing? Construction Digital

No Trump Drug Pricing Plan for J&J—Yet - BioSpace

Tue, 14 Oct 2025 07:00:00 GMT

No Trump Drug Pricing Plan for J&J—Yet BioSpace

J&J stock drops after Q4 2025 results (JNJ:NYSE) - Seeking Alpha

Wed, 21 Jan 2026 08:00:00 GMT

J&J stock drops after Q4 2025 results (JNJ:NYSE) Seeking Alpha

Coherus Oncology announces deal with J&J - The Pharma Letter

Thu, 05 Feb 2026 08:00:00 GMT

Coherus Oncology announces deal with J&J The Pharma Letter

J&J flexes $15B quarter for innovative drugs as biosimilars chip away at Stelara - Fierce Pharma

Wed, 16 Jul 2025 07:00:00 GMT

J&J flexes $15B quarter for innovative drugs as biosimilars chip away at Stelara Fierce Pharma

Baltimore jury orders J&J to pay $1.5B in largest-ever award to a talc plaintiff - Fierce Pharma

Tue, 23 Dec 2025 08:00:00 GMT

Baltimore jury orders J&J to pay $1.5B in largest-ever award to a talc plaintiff Fierce Pharma

J&J Wins Expansion for Top-Selling Cancer Drug in First for Smoldering Multiple Myeloma - BioSpace

Fri, 07 Nov 2025 08:00:00 GMT

J&J Wins Expansion for Top-Selling Cancer Drug in First for Smoldering Multiple Myeloma BioSpace

J&J’s Darzalex nets first self-administered cancer injectable approval - Pharmaceutical Technology

Fri, 27 Mar 2026 07:00:00 GMT

J&J’s Darzalex nets first self-administered cancer injectable approval Pharmaceutical Technology

AstraZeneca escalates EGFR lung cancer rivalry with J&J as Tagrisso combo posts survival win - Fierce Pharma

Sun, 07 Sep 2025 07:00:00 GMT

AstraZeneca escalates EGFR lung cancer rivalry with J&J as Tagrisso combo posts survival win Fierce Pharma

J&J earmarks $2bn for facility in North Carolina - pharmaphorum

Thu, 21 Aug 2025 07:00:00 GMT

J&J earmarks $2bn for facility in North Carolina pharmaphorum

Isomorphic signs another pharma deal, partnering with J&J for AI-made drugs - Endpoints News

Tue, 20 Jan 2026 08:00:00 GMT

Isomorphic signs another pharma deal, partnering with J&J for AI-made drugs Endpoints News